Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Completed · Phase 4

Conditions studied: Scalp Psoriasis

In brief

The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.

Key facts

Study ID

NCT00881868

Run by

Galderma R&D

People needed

81

Starts

2009-04-01

Expected to finish

2009-12-01

Last updated by the study team

2022-08-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with diagnosis of moderate to severe plaque psoriasis of the scalp

You may not qualify if…

• Subjects who need systemic treatment for their body psoriasis
• Subjects who have surface area involvement too large (>20% Body Surface Area [BSA]) that would require more than 50 grams per week of study product

Where it is running

• Dermatology Research Associates — Los Angeles, California, United States
• Hudson Dermatology — Evansville, Indiana, United States
• Research Division of The Skin Specialty Group — New York, New York, United States
• Dermatology Associates, PLLC — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.